Gary Calandra

8.3k citations
108 papers · 7.1k · 3 hit papers · h-index 40

Impact in

  • Hematology top 0.5%
    • Hematopoietic Stem Cell Transplantation
  • Hepatology top 2%
    • Hepatitis Viruses Studies and Epidemiology

Papers in

    • Hematopoietic Stem Cell Transplantation 38
    • Antibiotics Pharmacokinetics and Efficacy 11

Gary Calandra

105 papers receiving 6.5k citations

Gary Calandra's Hit Papers

Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma 2009 · 574 citations
5740+7+15Years since publication250500750

Peers

Gary Calandra
Comparison fields: 5 of 115
  • Hematology 2.6k
  • Hepatology 513
  • Microbiology 316
  • Oncology 993
  • Pharmacology 534
Replace Nicolas Dupin with:
Nicolas Dupin France
Chiara Azzari Italy
Carlos V. Payá United States
Dominik Selleslag Belgium
Daniele Focosi Italy
Magne Kristoffer Fagerhol Norway
Ineke J. M. ten Berge Netherlands
Michael M. Frank United States
É. Rosenthal France
A. D. B. WEBSTER United Kingdom
Gary Calandra relative to Nicolas Dupin France Nicolas Dupin's profile →
Citations per field
00.5×5×10×15×20×23.4×
Nicolas Dupin · 1×
Citations per year

Countries citing papers authored by Gary Calandra

Since Specialization
Citations

This map shows the geographic impact of Gary Calandra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Calandra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Calandra more than expected).

Fields of papers citing papers by Gary Calandra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Calandra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Calandra. The network helps show where Gary Calandra may publish in the future.

Co-authors

The 25 scholars most cited alongside Gary Calandra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gary Calandra Line = papers co-authored together Gary Calandra links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 108 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist
Hit paper breakdown →
2005942
2
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist
Hit paper breakdown →
2003613
3
Phase III Prospective Randomized Double-Blind Placebo-Controlled Trial of Plerixafor Plus Granulocyte Colony-Stimulating Factor Compared With Placebo Plus Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients With Non-Hodgkin's Lymphoma
Hit paper breakdown →
2009574
4 1992434
5 2004358
6 2008259
7 1991257
8 2005189
9 1988185
10 1992170
11 1982154
12 1988130
13 1985121
14 2009116
15 2008111
16 2007110
17 2009105
18 200989
19 198588
20 199182

About Gary Calandra

Gary Calandra is a scholar working on Hematology, Pharmacology, Public Health, Environmental and Occupational Health, Microbiology and Infectious Diseases, having authored 108 papers that have together received 7.1k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (38 papers), Streptococcal Infections and Treatments (18 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers), Hepatitis B Virus Studies (7 papers), HIV/AIDS drug development and treatment (6 papers), Hepatitis Viruses Studies and Epidemiology (6 papers), Bacterial Infections and Vaccines (6 papers) and Orthopedic Infections and Treatments (5 papers). The work is most often cited by research in Hematology (2.6k citations), Hepatology (513 citations), Microbiology (316 citations), Oncology (993 citations) and Pharmacology (534 citations). Gary Calandra has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Gary J Bridger, John F. DiPersio, David C. Dale, Hal E. Broxmeyer, Wayne Conrad Liles, Scott H. Cooper, Giao Hangoc, Karin Badel, Richard Thomas Maziarz and Ivana N. Micallef. Their work appears in journals such as Transplantation and Cellular Therapy, Clinical Infectious Diseases, Infection and Immunity, Blood and Vaccine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact